May 10, 2026 The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial
May 7, 2026 Nine-Protein Plasma Signature Predicts Kidney Events and Mortality in High-Risk APOL1 Patients
